Viewpoints: A New Roadmap in Eczema Care

New strategies in clinical care and advocacy will be essential in this emerging era of eczema management.
July 30, 2015

For the first time in decades, there is a healthy pipeline of new eczema drugs in development, including the first biologic drug indicated for moderate to severe eczema. All this development will bring profound change for physicians. It will also bring misconceptions and bewilderment as patients, payers, medical practices, government, and medical academia all scramble to understand eczema’s changing healthcare landscape as it pertains to their respective needs.